Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 1
1969 1
1970 3
1971 1
1972 2
1973 4
1979 1
1981 1
1983 2
1986 1
1987 2
1988 1
1989 1
1991 4
1992 2
1993 2
1994 2
1995 5
1996 2
1997 3
1998 8
1999 7
2000 7
2001 14
2002 7
2003 12
2004 5
2005 7
2006 7
2007 5
2008 8
2009 4
2010 6
2011 8
2012 11
2013 16
2014 5
2015 15
2016 8
2017 9
2018 3
2019 4
2020 8
2021 5
2022 9
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 11696644

231 results

Results by year

Filters applied: . Clear all
Page 1
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J. Matthay KK, et al. J Nucl Med. 2012 Jul;53(7):1155-63. doi: 10.2967/jnumed.111.098624. Epub 2012 Jun 14. J Nucl Med. 2012. PMID: 22700000 Free article.
Total-body and red marrow dose estimates.
Siegel JA, Stabin MG, Sparks RB. Siegel JA, et al. J Nucl Med. 2003 Feb;44(2):320-1; author reply 321-3. J Nucl Med. 2003. PMID: 12571225 Free article. No abstract available.
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM. Matthay KK, et al. J Clin Oncol. 2006 Jan 20;24(3):500-6. doi: 10.1200/JCO.2005.03.6400. J Clin Oncol. 2006. PMID: 16421427 Clinical Trial.
231 results